» Articles » PMID: 36917948

The Evolving Tumor Microenvironment: From Cancer Initiation to Metastatic Outgrowth

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2023 Mar 14
PMID 36917948
Authors
Affiliations
Soon will be listed here.
Abstract

Cancers represent complex ecosystems comprising tumor cells and a multitude of non-cancerous cells, embedded in an altered extracellular matrix. The tumor microenvironment (TME) includes diverse immune cell types, cancer-associated fibroblasts, endothelial cells, pericytes, and various additional tissue-resident cell types. These host cells were once considered bystanders of tumorigenesis but are now known to play critical roles in the pathogenesis of cancer. The cellular composition and functional state of the TME can differ extensively depending on the organ in which the tumor arises, the intrinsic features of cancer cells, the tumor stage, and patient characteristics. Here, we review the importance of the TME in each stage of cancer progression, from tumor initiation, progression, invasion, and intravasation to metastatic dissemination and outgrowth. Understanding the complex interplay between tumor cell-intrinsic, cell-extrinsic, and systemic mediators of disease progression is critical for the rational development of effective anti-cancer treatments.

Citing Articles

Contribution of tumor microenvironment (TME) to tumor apoptosis, angiogenesis, metastasis, and drug resistance.

Xiao Y, Hassani M, Moghaddam M, Fazilat A, Ojarudi M, Valilo M Med Oncol. 2025; 42(4):108.

PMID: 40087196 DOI: 10.1007/s12032-025-02675-8.


Significance of mouse xenograft tumor model using patient-derived cancer organoids for clinical drug development.

Ogawa H, Yoshida K, Hasegawa S, Wada H, Yasui M, Tahara H Front Oncol. 2025; 15:1485886.

PMID: 40078183 PMC: 11896854. DOI: 10.3389/fonc.2025.1485886.


A Review of Talin- and Integrin-Dependent Molecular Mechanisms in Cancer Invasion and Metastasis.

Baster Z, Russell L, Rajfur Z Int J Mol Sci. 2025; 26(5).

PMID: 40076426 PMC: 11899650. DOI: 10.3390/ijms26051798.


Potential prognostic biomarker of OSBPL10 in pan-cancer associated with immune infiltration.

Qi J, Yu K, Liu B, Wang Y, Wang W, An R Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40074843 DOI: 10.1007/s00210-025-03998-z.


Emerging insights into the gut microbiota as a key regulator of immunity and response to immunotherapy in hepatocellular carcinoma.

Ren S, Zhang Y, Wang X, Su J, Wang X, Yuan Z Front Immunol. 2025; 16:1526967.

PMID: 40070843 PMC: 11893557. DOI: 10.3389/fimmu.2025.1526967.